quantification major plasma protease inhibitors genetic typing NUMBER patients chronic obstructive pulmonary disease NUMBER control subjects normal ventilatory function similar respect age race sex significant increase frequency piz gene pi mz phenotype patients compared control subjects evidence primary deficiency antiprotease mean concentration inhibitor significantly lower patients control subjects moderate deficiency noted patients data indicate increased risk developing chronic obstructive pulmonary disease persons pi mz phenotype suggest possible relationship diseases low serum concentrations inhibitor alpha1 antirypsin alpha1 antitrypsin inter alpha trypsin alpha1 antichymotrypsin alpha1 antirypsin inter alpha trypsin